Among all the over-the-counter medicines out there, few are better known than aspirin, but taking this medicine too often can ...

Data looking at over 270 million patient encounters suggests that the use of daily baby aspirin to prevent heart disease has fallen by half since 2018. This decrease mirrors changing guidelines from ...

Arthur, who was born in January 2025, contracted parvovirus and had to have an intrauterine transfusion NHSBT A rare intrauterine transfusion was performed on an unborn baby at 16 weeks, making him ...

Daily aspirin does not reliably prevent bowel cancer in people at average risk, according to a major new review. Any potential protective effect may take more than a decade to appear — if it appears ...

Whether you’re trying to prevent blood clots or have been prescribed a blood thinner to treat atrial fibrillation (AFib), Eliquis (apixaban) and warfarin are two of the most commonly-used medications.

Colorectal, or bowel, cancer is the third most common cancer worldwide, making up 10% of cancer diagnoses. It most commonly affects people over the age of 50, but cases in younger people are ...

A new study has ignited the debate over whether every pregnant woman should take low-dose aspirin. Aspirin is cheap, widely available and generally safe, which makes it tempting to give it to everyone ...

A new study has ignited the debate over whether every pregnant woman should take low-dose aspirin. For years, it has been recommended for women at high risk of pre-eclampsia. This dangerous condition ...

Patients living with Atrial Fibrillation, or AFib, are typically prescribed an anticoagulant – blood thinner medication – to reduce the risk of stroke. However, some patients may soon be able to ...

Aspirin is one of the most familiar medicines in the world. Many people keep it at home to relieve pain, reduce fever, or ease inflammation. Over the years, aspirin has also become well known for its ...

FRANKFURT, Feb 5 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Thursday its experimental blood thinner cut the risk of stroke recurrence by 26% in a late-stage trial, in a fresh boost for CEO ...